[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:renal-cell-carcinoma-with-mit-translocations":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":22,"states":23},"Renal Cell Carcinoma with MiT Translocations",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07123090","A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma",[11],"Phase 2","RECRUITING","2026-08-26T02:16:51.982021Z","2026-05-05T02:43:28.844644Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06835972","A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)",[19],"Phase 1\u002FPhase 2","2026-08-26T02:17:42.501124Z","2026-04-29T02:57:57.071659Z",[],[]]